Insulet, insulin-management device maker, raises $116M in IPO
Insulet, a Bedford, Mass, developer of continuous insulin-infusion devices for diabetics, sold 7.7 million shares in an IPO, raising approximately $115 million before fees. The offering was priced at $15 per share, in the middle of Insulet’s range of $14 to $16. Insulet shares rose 6.9% on their first day of trading.
The company manufactures a patch-style device that continuously infuses insulin through the skin via a flexible needle-like tube, combined with a wireless device that… Continue Reading